Equity Details
Price & Market Data
Price: $1.98
Daily Change: +$0.13 / 6.57%
Daily Range: $1.83 - $1.98
Market Cap: $9,182,281
Daily Volume: 21,372
Performance Metrics
1 Week: -9.13%
1 Month: -62.05%
3 Months: -93.25%
6 Months: -96.99%
1 Year: -99.85%
YTD: -94.09%
About CDT Equity Inc. (CDT)
Gain a deep understanding of CDT Equity Inc. (CDT). The stock is trading at 1.98, showing a daily change of +$0.13 / 6.57%. Its market capitalization is 9,182,281. Performance over 1-week (-9.13%) and 6-month (-96.99%) periods offer valuable insights.
Company Details
Employees: 4
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.